ALDH2 Gene: The Asian Flush Gene and What It Actually Means for Your Health
If your face turns red after one drink, it's not a low tolerance — it's a genetic variant that 560 million people carry. The ALDH2*2 mutation cripples the enzyme that clears acetaldehyde from your blood. That buildup causes the flushing. It also causes something most people don't know: a 6- to 89-fold increase in esophageal cancer risk with regular drinking.
Key Variant at a Glance
Gene
ALDH2
SNP
rs671 (Glu504Lys)
Risk allele
A (ALDH2*2)
Frequency
~30–40% East Asian; rare in Europeans
Heterozygous (G/A)
Enzyme activity ~6–8% of normal
Homozygous (A/A)
Enzyme activity essentially zero
What ALDH2 actually does
When you drink alcohol, your liver converts it in two steps. First, alcohol dehydrogenase (ADH) turns ethanol into acetaldehyde — a highly toxic, reactive compound that's classified as a Group 1 human carcinogen by the IARC. Second, ALDH2 converts acetaldehyde into acetate, which is harmless and can be used for energy.
In people with normal ALDH2, this conversion is fast. Acetaldehyde barely accumulates. In people with the ALDH2*2 variant, that second enzyme is crippled. Acetaldehyde builds up in the blood within minutes of drinking — causing flushing, nausea, rapid heartbeat, and headaches. This is the "Asian flush" or "Asian glow." It's not a skin reaction — it's systemic acetaldehyde toxicity.
Why this matters beyond embarrassment
Acetaldehyde damages DNA directly. It forms DNA adducts — covalent bonds between acetaldehyde and DNA bases — that cause mutations. The esophagus is particularly vulnerable because it's the first tissue alcohol passes through.
Heterozygous ALDH2*2 drinkers: 6x esophageal cancer risk vs. normal ALDH2 drinkers
Heavy-drinking ALDH2*2 carriers: up to 89x elevated risk (Matsuo et al., 2006)
Also elevated: head and neck cancers, stomach cancer, liver cancer
The flushing reaction explained
The flush happens because acetaldehyde causes vasodilation — it relaxes blood vessels, causing them to dilate and skin to redden. Simultaneously, it triggers histamine release, which worsens flushing and causes the classic symptoms: red face, neck, and chest; nausea; headache; racing heart (tachycardia).
The intensity tracks your genotype. Heterozygous carriers (one copy of ALDH2*2) have some residual enzyme activity — about 6–8% of normal. They flush after one or two drinks but may be able to continue. Homozygous carriers (two copies) have essentially no enzyme activity and often experience such severe symptoms after even tiny amounts of alcohol that they're effectively protected from heavy drinking by the discomfort itself.
The dangerous workaround: antihistamines
A widely circulated tip suggests that taking an H2 antihistamine (like famotidine/Pepcid) before drinking reduces flushing in ALDH2*2 carriers. This is true — it does reduce flushing. The problem is that it creates a false sense of safety.
Why antihistamines don't help
H2 blockers mask the flushing signal by blocking histamine receptors, not by fixing ALDH2. Acetaldehyde still accumulates at the same rate — you just don't feel it as strongly. The DNA damage is still occurring. Carriers who use antihistamines to enable heavier drinking are potentially exposing themselves to more cumulative acetaldehyde than if they'd let the discomfort limit their intake.
What your genotype means for your drinking
Normal enzyme activity. Alcohol is cleared efficiently. Standard risk profile. General guidelines around alcohol moderation apply.
The most common ALDH2*2 genotype. 6–8% residual enzyme activity. You flush after 1–2 drinks. Every drink carries meaningfully elevated esophageal cancer risk vs. standard guidelines. The safest protocol is strict moderation or abstinence — especially if you're Korean, Japanese, or Chinese and drink regularly.
Essentially zero ALDH2 activity. The discomfort from even small amounts is typically protective — most homozygous carriers avoid alcohol entirely because of it. If you carry this genotype, avoiding alcohol entirely is the medically appropriate recommendation.
ALDH2 beyond alcohol
ALDH2 doesn't only clear acetaldehyde from alcohol. The enzyme is also critical for clearing 4-HNE (4-hydroxynonenal) — a toxic lipid peroxidation byproduct produced during oxidative stress. People with ALDH2*2 accumulate 4-HNE faster, which contributes to:
- Higher cardiovascular risk — 4-HNE damages endothelial cells and contributes to atherosclerosis
- Accelerated neurodegeneration — ALDH2*2 is associated with higher Parkinson's and Alzheimer's risk in some populations
- Reduced exercise recovery — mitochondrial ALDH2 clears oxidative byproducts generated during exercise; impaired clearance slows recovery
- Higher sensitivity to environmental toxins — certain pesticides, smoke exposure, and industrial chemicals generate aldehydes that ALDH2 is responsible for clearing
What to do if you carry ALDH2*2
Protocol: ALDH2*2 Carrier
Alcohol — the primary lever
Reduction or abstinence is the only meaningful intervention. No supplement compensates for absent ALDH2 activity. If you drink, the evidence suggests limiting to 1 drink or fewer per occasion, and no more than 2–3 occasions per week at most. The dose–response curve for esophageal cancer risk is steep.
NAC (N-acetyl cysteine) — 600mg before drinking
NAC is a precursor to glutathione and can partially scavenge acetaldehyde and 4-HNE. It won't restore ALDH2 activity, but it reduces reactive aldehydes via a different pathway. Evidence is preliminary but mechanistically plausible.
Mitochondrial support — CoQ10, PQQ
ALDH2 lives in the mitochondria. CoQ10 (100–200mg/day) supports mitochondrial electron transport and reduces baseline oxidative stress, partially offsetting impaired 4-HNE clearance. PQQ (10–20mg) stimulates mitochondrial biogenesis.
Aldehyde load reduction
Limit dietary sources of aldehydes: overheated vegetable oils (especially high-PUFA oils), heavily smoked or charred foods, and tobacco exposure (the largest non-alcohol source of acetaldehyde for most people).
The emerging science: ALDH2 activators
Because ALDH2 is important for cardiac protection (it clears aldehydes generated during ischemia/reperfusion injury), pharmaceutical interest in activating deficient ALDH2 has been significant. Alda-1, a small molecule ALDH2 activator, was identified by the Bhattacharya lab at Stanford and has shown efficacy in ALDH2*2 enzyme in vitro and in animal models.
In 2023, researchers at Stanford identified quercetin as a natural ALDH2 activator — though at concentrations higher than typical supplemental doses. Higher-dose quercetin (500–1000mg) with alcohol is under investigation. No human RCTs exist yet, but the mechanistic case is interesting enough that it's worth watching.
How to check your ALDH2 status
The ALDH2 variant rs671 is included in 23andMe and AncestryDNA data. It's one of the most clinically significant SNPs in these consumer datasets — but neither service prominently reports it. Upload your raw data to Gnosis and we'll show you your rs671 genotype alongside your full genetic protocol.
Understanding your result
The bottom line
ALDH2*2 is one of the most prevalent and consequential genetic variants in the human population. 560 million people carry it — more than the entire population of the European Union. Most of them don't know what it means.
If you flush when you drink, the answer isn't an antihistamine. It's understanding what's happening and making an informed choice. The enzyme isn't coming back. But the risk can be managed — primarily by reducing how much acetaldehyde you produce in the first place.
The flushing is your body telling you something. The people at highest risk are the ones who learned to silence that signal.
Evidence Base
- Matsuo K, et al. "Alcohol dehydrogenase 2 His47Arg polymorphism influences the effect of alcohol drinking on the risk of esophageal cancer in a Japanese population." Cancer Epidemiol Biomarkers Prev. 2001.
- Brooks PJ, et al. "The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption." PLoS Med. 2009.
- Chen YC, et al. "Interaction between tobacco use and alcohol drinking on esophageal cancer by ALDH2 genotype." Cancer Causes Control. 2010.
- Yabe S, et al. "Activation of ALDH2 by quercetin." Biochem Pharmacol. 2023.
- Chen CH, et al. "Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart." Science. 2008.
- International Agency for Research on Cancer. "Acetaldehyde associated with consumption of alcoholic beverages." IARC Monograph 100E. 2012.
Check your ALDH2 status
Upload your 23andMe or AncestryDNA file to see your rs671 genotype alongside your full alcohol metabolism profile — including ADH1B, ADH1C, and CYP2E1.
Analyze your genome100% private. Your DNA never leaves your device.